Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction.

J Cardiovasc Dev Dis · 2021 · PMC8539734 · PMID 34677198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

clearly significantno p-value reported

Discussion A clearly significant mortality reduction in the acute phase and long-term mortality induced by Levosimendan in AMI is evident.

also in 627 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.